Plain-English translation of NCT04240366 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding an extra step to a standard heart rhythm procedure — isolating the left atrial appendage in addition to the pulmonary veins — helps prevent atrial fibrillation from coming back. You would receive a balloon-based ablation procedure, and depending on which group you're in, that procedure might include this additional isolation step. The goal is to see if this combination approach works better than the standard approach alone.
Persistent atrial fibrillation is a serious heart rhythm problem that's hard to treat. Even after standard procedures, the condition often comes back. Researchers believe that isolating an additional part of the heart during the initial procedure might prevent recurrence and improve long-term outcomes for patients.
You likely qualify if…
You likely don't qualify if…
You will undergo a balloon-based ablation procedure as your main treatment. Half of participants will receive the standard procedure (isolating the pulmonary veins only), while the other half will receive the standard procedure plus the additional isolation step. After the procedure, you may take an anti-arrhythmic medication for up to 3 months and will be followed according to standard care guidelines. If your atrial fibrillation returns, repeat procedures may be offered after the first 3 months.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Germany